Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NAPRAPATPLUSS SØRLANDETS IDRETTSKLINIKK AS
AS
Active
Org 931515152
Industrigata 6, 4632 Kristiansand S
Traditional, complementary and alternative medicine activities · NACE 8696
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 1,1M
+8% vs 2023
EBITDA margin
6.2%
+770% vs 2023
Equity ratio
87.5%
Financial strength
Net profit 2024
NOK 51K
+121% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 1,1M
+8%
EBITDA
NOK 69K
+770%
Net profit
NOK 51K
+121%
Total assets
NOK 75K
-71%
Equity
NOK 65K
+123%
Employees
1
—
Company information
Legal name
NAPRAPATPLUSS SØRLANDETS IDRETTSKLINIKK AS
Org number
931515152
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
5. juni 2023
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Helsetjenester, manuell behandling, kursvirksomhet og annet som står i naturlig forbindelse med dette.
Contact
Address
Industrigata 6, 4632 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Traditional, complementary and alternative medicine activities
Companies in Kristiansand
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
1 028
1 107
Staff expenses
−199
−2
EBITDA
−10
69
Depreciation & amort.
−2
−28
EBIT
−12
41
Net financials
1
0
Profit before tax
−12
41
Tax
236
−10
Net profit
−248
51
Balance sheet
NOK thousands
Item
2023
2024
Total assets
259
75
Equity
−286
65
Long-term debt
0
0
Short-term debt
544
9
Total debt
544
9
Financial ratios
5-year trend
EBITDA margin
6.2%
This company
15.8%
Market median
-61% vs market
2023
2024
Equity ratio
87.5%
This company
38.2%
Market median
+129% vs market
2023
2024
Return on equity
78.1%
This company
18.4%
Market median
+324% vs market
2023
2024
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
2023
2024
Asset turnover
14.82×
This company
1.12×
Market median
+1223% vs market
2023
2024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KE
Kasper Emil Pedersen
Chief Executive Officer
Chief Executive Officer
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KG
Kennet Gard
Chairman
2023
JJ
Jacob Just
Chairman
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ache As
Company
33.33%
33.33%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Ache As
NAPRAPATPLUSS SØRLANDETS IDRETTSKLINIKK AS
(this company)
Board network connections
Board members of NAPRAPATPLUSS SØRLANDETS IDRETTSKLINIKK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kasper Emil Pedersen
Chief Executive Officer
0 companies
Kennet Gard
Chairman
0 companies
Jacob Just
Chairman
0 companies